iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
56 hedge funds and large institutions have $54.9M invested in iShares Genomics Immunology and Healthcare ETF in 2025 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.34% more ownership
Funds ownership: 41.36% → 41.69% (+0.34%)
Holders
56
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.51M | |
| 2 | +$741K | |
| 3 | +$352K | |
| 4 |
FTUS
Flow Traders U.S.
New York
|
+$352K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$326K |
Top Sellers
| 1 | -$1.9M | |
| 2 | -$553K | |
| 3 | -$328K | |
| 4 |
WBG
Wharton Business Group
Malvern,
Pennsylvania
|
-$325K |
| 5 |
SWGC
Summit Wealth Group (Colorado)
Colorado Springs,
Colorado
|
-$292K |
